Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Finch Therapeutics Group Inc stock (Finch Therapeutics Group Inc)

Buy Finch Therapeutics Group Inc stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Finch Therapeutics Group Inc is a biotechnology business based in the US. Finch Therapeutics Group Inc shares (FNCH) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $12.05 – an increase of 4.78% over the previous week. Finch Therapeutics Group Inc employs 1 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Finch Therapeutics Group stock

Best for mobile experience

Go to site
  • Earn 4.5% interest on uninvested cash with Gold
  • Get up to $50,000 in instant deposits with Gold
  • Easy, user-friendly trading
  • Unlimited bonus amounts Oct 16-27

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

How to buy Finch Therapeutics Group Inc stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – FNCH. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Finch Therapeutics Group Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Robinhood
Finder Score: 4.4 / 5: ★★★★★
Bonus
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Earn 1–3% on transfers from Oct 16–27
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
eToro
Finder Score: 4 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.9%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Finch Therapeutics Group Inc stock price (PINK: FNCH)

Use our graph to track the performance of FNCH stocks over time.

Finch Therapeutics Group Inc shares at a glance

Information last updated 2024-10-15.
Latest market close$12.05
52-week range$0.80 - $14.26
50-day moving average $10.88
200-day moving average $4.39
Wall St. target price$90.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-8.80

Finch Therapeutics Group Inc price performance over time

Historical closes compared with the close of $12 from 2024-10-15

1 week (2024-10-10) 4.35%
1 month (2024-09-17) 4.35%
3 months (2024-07-17) 721.92%
6 months (2024-04-17) 376.19%
1 year (2023-10-17) 179.07%
2 years (2022-10-17) 664.33%
3 years (2021-10-15) 0.42%
5 years (2019-10-13) N/A

Finch Therapeutics Group Inc financials

Gross profit TTM $-57,032,000
Return on assets TTM -21.89%
Return on equity TTM -67.28%
Profit margin 0%
Book value $8.86
Market Capitalization $18.7 million

TTM: trailing 12 months

Have Finch Therapeutics Group Inc's shares ever split?

Finch Therapeutics Group Inc's shares were split on a 1:30 basis on 11 June 2023. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Finch Therapeutics Group Inc shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Finch Therapeutics Group Inc shares which in turn could have impacted Finch Therapeutics Group Inc's share price.

Finch Therapeutics Group Inc share price volatility

Over the last 12 months, Finch Therapeutics Group Inc's shares have ranged in value from as little as $0.8 up to $14.26. A popular way to gauge a stock's volatility is its "beta".

FNCH.US volatility(beta: 1.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Finch Therapeutics Group Inc's is 1.329. This would suggest that Finch Therapeutics Group Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Finch Therapeutics Group Inc's beta into context you can compare it against those of similar companies.

Finch Therapeutics Group Inc overview

Finch Therapeutics Group, Inc. , a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts. .

Frequently asked questions

null
What percentage of Finch Therapeutics Group Inc is owned by insiders or institutions?
Currently 53.457% of Finch Therapeutics Group Inc shares are held by insiders and 4.63% by institutions.
How many people work for Finch Therapeutics Group Inc?
Latest data suggests 1 work at Finch Therapeutics Group Inc.
When does the fiscal year end for Finch Therapeutics Group Inc?
Finch Therapeutics Group Inc's fiscal year ends in December.
Where is Finch Therapeutics Group Inc based?
Finch Therapeutics Group Inc's address is: 75 State Street, Boston, MA, United States, 02109
What is Finch Therapeutics Group Inc's ISIN number?
Finch Therapeutics Group Inc's international securities identification number is: US31773D1019

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site